2025 H2 -tulosraportti
157 päivää sitten
‧38 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·18 min sittenI particularly noticed this wording in the stock exchange announcement: "Together with our partners and suppliers, we have laid the foundation for Thor Medical's next growth phase, where we continue to expand capacity and serve customers worldwide." To me, this is an important sentence. Management does not speak as if the job is done because AlphaOne has started commercial production. On the contrary, they describe this as the foundation for the next growth phase. They also point out that they will continue to expand capacity, which aligns well with the plan for gradual scaling up of AlphaOne and the company's long-term ambitions. I interpret this as the focus now shifting from "can they start production?" to "how quickly can they scale production and serve an increasingly larger global market?" What do you think – has the market noticed this wording enough?
·3 t sittenDon't forget that a poor capital company is sitting on 1.8 million shares short. There's guaranteed to be a wild ketchup effect when they also have to cover. Remember also that all the flies want in on Thor and equity funds are loading up, so sit on your shares. This could be a new Algeta Biotek success in Norway. Thor can go up several hundred percent. Remember that Nel went completely crazy up from kr 1.14 to kr 32 and Nel lost several hundred million a year 🤠 Many I know became millionaires just by calmly sitting on the hydrogen hype. Doubling down on biotech like Thor is peanuts. New millionaires can be created here. Stay calm. Sit calmly and buy more is my advice.
If short didn't get their butt in gear and sold on Friday, then they can have it so good 😂😂
·6 t sittenhttps://www.heroya-industripark.no/en/news/2026/thor-medical-asa-alphaone-starts-commercial-production Does anyone know how many units are forecast in 2026-2027-2028?
Yes, the company has said that one can scale up. The question is probably not if, but rather when.- ·7 t sitten · MuokattuAnyone have info on POC* on Friday?
- ·21 t sittenInvest tech's technical analysis: Automatic technical analysis. Medium term, 31. Jul 2026 Thor Medical ASA is in a rising trend channel in the medium term. This shows that investors over time have bought at increasingly higher prices to get into the stock and indicates a good development for the company. The stock is moving in a rectangle formation between support at 3.92 kroner and resistance at 5.95 kroner. An established break of one of these levels will signal further direction. The stock has broken up through the resistance at approximately 5.50 kroner. Further upside is thus signaled, and there is now support at 5.50 kroner on reactions back. Volume has previously been high around price tops and low around price bottoms. The volume balance is also positive, which strengthens the trend picture. RSI is above 70 after a good price increase in recent weeks. The stock has strong positive momentum and further upside is indicated.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H2 -tulosraportti
157 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·18 min sittenI particularly noticed this wording in the stock exchange announcement: "Together with our partners and suppliers, we have laid the foundation for Thor Medical's next growth phase, where we continue to expand capacity and serve customers worldwide." To me, this is an important sentence. Management does not speak as if the job is done because AlphaOne has started commercial production. On the contrary, they describe this as the foundation for the next growth phase. They also point out that they will continue to expand capacity, which aligns well with the plan for gradual scaling up of AlphaOne and the company's long-term ambitions. I interpret this as the focus now shifting from "can they start production?" to "how quickly can they scale production and serve an increasingly larger global market?" What do you think – has the market noticed this wording enough?
- ·3 t sittenDon't forget that a poor capital company is sitting on 1.8 million shares short. There's guaranteed to be a wild ketchup effect when they also have to cover. Remember also that all the flies want in on Thor and equity funds are loading up, so sit on your shares. This could be a new Algeta Biotek success in Norway. Thor can go up several hundred percent. Remember that Nel went completely crazy up from kr 1.14 to kr 32 and Nel lost several hundred million a year 🤠 Many I know became millionaires just by calmly sitting on the hydrogen hype. Doubling down on biotech like Thor is peanuts. New millionaires can be created here. Stay calm. Sit calmly and buy more is my advice.If short didn't get their butt in gear and sold on Friday, then they can have it so good 😂😂
- ·6 t sittenhttps://www.heroya-industripark.no/en/news/2026/thor-medical-asa-alphaone-starts-commercial-production Does anyone know how many units are forecast in 2026-2027-2028?Yes, the company has said that one can scale up. The question is probably not if, but rather when.
- ·7 t sitten · MuokattuAnyone have info on POC* on Friday?
- ·21 t sittenInvest tech's technical analysis: Automatic technical analysis. Medium term, 31. Jul 2026 Thor Medical ASA is in a rising trend channel in the medium term. This shows that investors over time have bought at increasingly higher prices to get into the stock and indicates a good development for the company. The stock is moving in a rectangle formation between support at 3.92 kroner and resistance at 5.95 kroner. An established break of one of these levels will signal further direction. The stock has broken up through the resistance at approximately 5.50 kroner. Further upside is thus signaled, and there is now support at 5.50 kroner on reactions back. Volume has previously been high around price tops and low around price bottoms. The volume balance is also positive, which strengthens the trend picture. RSI is above 70 after a good price increase in recent weeks. The stock has strong positive momentum and further upside is indicated.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
2025 H2 -tulosraportti
157 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·18 min sittenI particularly noticed this wording in the stock exchange announcement: "Together with our partners and suppliers, we have laid the foundation for Thor Medical's next growth phase, where we continue to expand capacity and serve customers worldwide." To me, this is an important sentence. Management does not speak as if the job is done because AlphaOne has started commercial production. On the contrary, they describe this as the foundation for the next growth phase. They also point out that they will continue to expand capacity, which aligns well with the plan for gradual scaling up of AlphaOne and the company's long-term ambitions. I interpret this as the focus now shifting from "can they start production?" to "how quickly can they scale production and serve an increasingly larger global market?" What do you think – has the market noticed this wording enough?
- ·3 t sittenDon't forget that a poor capital company is sitting on 1.8 million shares short. There's guaranteed to be a wild ketchup effect when they also have to cover. Remember also that all the flies want in on Thor and equity funds are loading up, so sit on your shares. This could be a new Algeta Biotek success in Norway. Thor can go up several hundred percent. Remember that Nel went completely crazy up from kr 1.14 to kr 32 and Nel lost several hundred million a year 🤠 Many I know became millionaires just by calmly sitting on the hydrogen hype. Doubling down on biotech like Thor is peanuts. New millionaires can be created here. Stay calm. Sit calmly and buy more is my advice.If short didn't get their butt in gear and sold on Friday, then they can have it so good 😂😂
- ·6 t sittenhttps://www.heroya-industripark.no/en/news/2026/thor-medical-asa-alphaone-starts-commercial-production Does anyone know how many units are forecast in 2026-2027-2028?Yes, the company has said that one can scale up. The question is probably not if, but rather when.
- ·7 t sitten · MuokattuAnyone have info on POC* on Friday?
- ·21 t sittenInvest tech's technical analysis: Automatic technical analysis. Medium term, 31. Jul 2026 Thor Medical ASA is in a rising trend channel in the medium term. This shows that investors over time have bought at increasingly higher prices to get into the stock and indicates a good development for the company. The stock is moving in a rectangle formation between support at 3.92 kroner and resistance at 5.95 kroner. An established break of one of these levels will signal further direction. The stock has broken up through the resistance at approximately 5.50 kroner. Further upside is thus signaled, and there is now support at 5.50 kroner on reactions back. Volume has previously been high around price tops and low around price bottoms. The volume balance is also positive, which strengthens the trend picture. RSI is above 70 after a good price increase in recent weeks. The stock has strong positive momentum and further upside is indicated.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt